3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Phase 1/2
3
Phase 3
2
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
12
Nasopharyngeal Carcinoma
8
Head and Neck Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Squamous Cell Carcinoma of Head and Neck
5
Esophageal Neoplasms
5
Recurrence
4
Nasopharyngeal Neoplasms
4
Lung Neoplasms
4
Carcinoma, Hepatocellular
4
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Ovarian Neoplasms
3
Osteosarcoma
3
Neuroblastoma
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Squamous Cell
3
Small Cell Lung Carcinoma
2
Peritoneal Neoplasms
2
Neoplasms
2
Hyperthermia
2
Fallopian Tube Neoplasms
2
Cholangiocarcinoma
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Virus Diseases
1
Tumor Virus Infections
1
Tongue Neoplasms
1
Interventions
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Nimorazole
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms, Squamous Cell
×
Cisplatin
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled